Target Name: MIR4676
NCBI ID: G100616286
Review Report on MIR4676 Target / Biomarker Content of Review Report on MIR4676 Target / Biomarker
MIR4676
Other Name(s): hsa-miR-4676-3p | hsa-mir-4676 | hsa-miR-4676-5p | microRNA 4676 | MicroRNA 4676

MIR4676: A Potential Drug Target and Biomarker

Molecular Targets in Medicine

MIR4676, also known as ITGB3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases.

Structure and Function

MIR4676 is a small non-coding RNA molecule that is approximately 200 amino acids long. It is expressed in various tissues and cells throughout the body and is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.

One of the key features of MIR4676 is its ability to interact with multiple protein partners, including casein kinase (CK) 18, which is a protein that is involved in a variety of cellular processes, including cell adhesion, migration, and survival. MIR4676 has been shown to physically interact with CK18 and can modulate its activity, suggesting that it may play a role in the regulation of these processes.

MIR4676 has also been shown to interact with the protein T-cell receptor (TCR), which is a critical regulator of T-cell development and function. MIR4676 has been shown to modulate the activity of TCR and has been identified as a potential drug target for T-cell disorders.

Disease Potential

MIR4676 has been shown to be involved in a variety of diseases and disorders, including cancer, neurodegenerative disorders, and autoimmune diseases.

In cancer, MIR4676 has been shown to be involved in the regulation of cell adhesion, migration, and survival. It has also been shown to promote the growth and survival of cancer cells. These findings suggest that MIR4676 may be a potential drug target for cancer.

In neurodegenerative disorders, MIR4676 has been shown to be involved in the regulation of neurotransmitter signaling and the maintenance of neuronal structure and function. It has also been shown to protect neuronal cells from neurotoxicity. These findings suggest that MIR4676 may be a potential drug target for neurodegenerative disorders.

In autoimmune diseases, MIR4676 has been shown to be involved in the regulation of immune cell function and the development of autoimmune diseases. It has also been shown to protect against the development of autoimmune diseases. These findings suggest that MIR4676 may be a potential drug target for autoimmune diseases.

MIR4676 as a Biomarker

MIR4676 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

In cancer, MIR4676 has been shown to be involved in the regulation of cell adhesion, migration, and survival. It has also been shown to promote the growth and survival of cancer cells. These findings suggest that MIR4676 may be a potential biomarker for cancer.

In neurodegenerative disorders, MIR4676 has been shown to be involved in the regulation of neurotransmitter signaling and the maintenance of neuronal structure and function. It has also been shown to protect neuronal cells from neurotoxicity. These findings suggest that MIR4676 may be a potential biomarker for neurodegenerative disorders.

In autoimmune diseases, MIR4676 has been shown to be involved in the regulation of immune cell function and the development of autoimmune diseases. It has also been shown to protect against the development of autoimmune diseases. These findings suggest that MIR4676 may be a potential biomarker for autoimmune diseases.

Conclusion

MIR4676 is a non-coding RNA molecule that has been shown to interact with multiple protein partners and has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases. Further research is needed to fully understand the role of MIR4676 in disease and to develop safe and effective drugs that target it.

Protein Name: MicroRNA 4676

The "MIR4676 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4676 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781